LISTEN: Biotech buyouts, CEO breakups, and The Rock does CRISPR
hy are biotech investors suddenly so exuberant? What does it mean when a CEO scrubs his LinkedIn profile? And can CRISPR turn your dog into a winged hellhound bent on destroying Chicago?
We discuss all that and more on the latest episode of “The Readout LOUD,” STAT’s biotech podcast. Stick around for a parsing of merger mania, a history lesson on biotech breakups, and the story of how a sleepy little cancer conference became a multimillion-dollar business. Also STAT reporter Megan Thielking joins us to talk about how Dwayne “The Rock” Johnson has brought gene editing to the big screen, and Adam mentions Four Loko.
And if you have any feedback for us — topics to cover, guests to invite, vocal tics to cease — you can email firstname.lastname@example.org.
Published at Thu, 12 Apr 2018 21:21:30 +0000